Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies
Kanneboyina Nagaraju(Children's National), Paul H. Plötz(National Institutes of Health), Tomasina Parker(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Gül Bahtiyar(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Lisa Loeffler(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Nina Raben(APT Therapeutics (United States)), Rob Hooft van Huijsduijnen(Merck (Germany)), Paul J. Rochon(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Ryuichi Wada(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Eunice Lee(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Carol L. Danning(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Cynthia D. Thompson(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Joseph Craft(Yale University)
Cited by 314
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
|The Journal of Experimental Medicine|2005|395